Key result
The E2-mi3 nanoparticle vaccine against CSFV conferred complete protection in rabbits and triggered stronger cellular and humoral immune responses in pigs compared to standard E2 vaccines.
Why the study?
Conventional classical swine fever vaccines face biosafety concerns and cannot distinguish vaccinated from infected animals, complicating disease eradication.
An innovative E2-mi3 nanoparticle vaccine demonstrates robust thermostability and elicits strong protective immunity against classical swine fever virus in animal models.
Classical swine fever virus (CSFV) is a highly contagious pathogen causing significant economic losses in the swine industry. Conventional inactivated or attenuated live vaccines for classical swine fever (CSF) are effective but face biosafety concerns and cannot distinguish vaccinated animals from those infected with the field virus, complicating CSF eradication efforts. It is noteworthy that nanoparticle (NP)-based vaccines resemble natural viruses in size and antigen structure, and offer an alternative tool to circumvent these limitations. In this study, we developed an innovative vaccine delivery scaffold utilizing self-assembled mi3 NPs, which form stable structures carrying the CSFV E2 glycoprotein. The expressed yeast E2-fused protein (E2-mi3 NPs) exhibited robust thermostability (25 to 70 °C) and long-term storage stability at room temperature (25 °C). Interestingly, E2-mi3 NPs made with this technology elicited enhanced antigen uptake by RAW264.7 cells. In a rabbit model, the E2-mi3 NP vaccine against CSFV markedly increased CSFV-specific neutralizing antibody titers. Importantly, it conferred complete protection in rabbits challenged with the C-strain of CSFV. Furthermore, we also found that the E2-mi3 NP vaccines triggered stronger cellular (T-lymphocyte proliferation, CD8+ T-lymphocytes, IFN-γ, IL-2, and IL-12p70) and humoral (CSFV-specific neutralizing antibodies, CD4+ T-lymphocytes, and IL-4) immune responses in pigs than the E2 vaccines. To sum up, these structure-based, self-assembled mi3 NPs provide valuable insights for novel antiviral strategies against the constantly infectious agents.
No takes yet. Share an insight, caveat, or question.
Song et al. (2024) studied Classical swine fever virus (CSFV) infection. E2-mi3 NP vaccine vs. E2 vaccines was evaluated on CSFV-specific neutralizing antibody titers, protection against challenge, and immune responses. The E2-mi3 nanoparticle vaccine against CSFV conferred complete protection in rabbits and triggered stronger cellular and humoral immune responses in pigs compared to standard E2 vaccines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: